tiprankstipranks
Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs (BR:BIIB34)
:BIIB34
Brazil Market
BIIB34
Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs
RESEARCH TOOLSreports

Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs (BIIB34) Price & Analysis

― Followers

BIIB34 Stock Chart & Stats

R$172.75
R$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeR$110.07 - R$200.11
Previous CloseN/A
VolumeN/A
Average Volume (3M)38.00
Market Cap
R$152.21B
Enterprise ValueR$181.20K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)34421.9
Beta-0.12
Next Earnings
Oct 29, 2026
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding886,506,300
10 Day Avg. Volume10
30 Day Avg. Volume38
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs News

Biogen price target raised to $241 from $221 at Mizuho
Biogen price target raised to $241 from $221 at Mizuho
Mizuho analyst Salim Syed raised the firm’s price target on Biogen (BIIB) to $241 from $221 and keeps...
2d ago
BIIB
Biogen price target raised to $215 from $200 at Citi
Biogen price target raised to $215 from $200 at Citi
Citi raised the firm’s price target on Biogen (BIIB) to $215 from $200 and keeps a Neutral rating...
3d ago
BIIB
Biogen price target raised to $231 from $222 at Morgan Stanley
Biogen price target raised to $231 from $222 at Morgan Stanley
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Biogen (BIIB) to $231 from $222 and...
7d ago
BIIB
Biogen price target raised to $251 from $237 at H.C. Wainwright
Biogen price target raised to $251 from $237 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Biogen (BIIB) to $251 from $237 and keeps a Buy...
7d ago
BIIB
Biogen price target lowered to $240 from $242 at RBC Capital
Biogen price target lowered to $240 from $242 at RBC Capital
RBC Capital lowered the firm’s price target on Biogen (BIIB) to $240 from $242 and keeps an Outperform...
7d ago
BIIB
Biogen price target raised to $240 from $225 at UBS
Biogen price target raised to $240 from $225 at UBS
UBS raised the firm’s price target on Biogen (BIIB) to $240 from $225 and keeps a Buy rating...
7d ago
BIIB
Biogen price target raised to $215 from $201 at Wedbush
Biogen price target raised to $215 from $201 at Wedbush
Wedbush analyst Laura Chico raised the firm’s price target on Biogen (BIIB) to $215 from $201 and keeps...
7d ago
BIIB
Biogen price target raised to $219 from $215 at BofA
Biogen price target raised to $219 from $215 at BofA
BofA analyst Jason Zemansky raised the firm’s price target on Biogen (BIIB) to $219 from $215 and keeps...
7d ago
BIIB
Biogen price target raised to $225 from $215 at TD Cowen
Biogen price target raised to $225 from $215 at TD Cowen
TD Cowen analyst Phil Nadeau raised the firm’s price target on Biogen (BIIB) to $225 from $215 and...
7d ago
BIIB
Biogen price target raised to $248 from $245 at Canaccord
Biogen price target raised to $248 from $245 at Canaccord
Canaccord raised the firm’s price target on Biogen (BIIB) to $248 from $245 and keeps a Buy rating...
7d ago
BIIB

BIIB34 FAQ

What was Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s price range in the past 12 months?
Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs lowest stock price was R$110.07 and its highest was R$200.11 in the past 12 months.
    What is Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s market cap?
    Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s market cap is R$152.21B.
      When is Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s upcoming earnings report date?
      Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s upcoming earnings report date is Oct 29, 2026 which is in 84 days.
        How were Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s earnings last quarter?
        Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs released its earnings results on Jul 29, 2026. The company reported R$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs overvalued?
          According to Wall Street analysts Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs pay dividends?
            Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs does not currently pay dividends.
            What is Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s EPS estimate?
            Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs have?
            Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs has 886,506,300 shares outstanding.
              What happened to Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs’s price movement after its last earnings report?
              Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs reported an EPS of R$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs?
                Currently, no hedge funds are holding shares in BR:BIIB34
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Biogen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1/6 Shs (BIIB34) Earnings & Revenues

                  Historic Earnings Reports
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  A1LN34
                  Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh
                  ―
                  ―
                  B1ME34
                  BeiGene Ltd ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR
                  ―
                  ―
                  B1NT34
                  BioNTech SE ADR Unsponsored Brazilian Depositary Receipt Repr 0.0625 ADR
                  ―
                  ―
                  I1NC34
                  Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
                  ―
                  ―
                  M1RN34
                  Moderna, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh
                  ―
                  ―
                  Compare BR:BIIB34 Stocks >
                  Popular Stocks